Bedel Financial Consulting’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-16
Closed -$1K 324
2022
Q1
$1K Sell
16
-17
-52% -$1.35K ﹤0.01% 914
2021
Q4
$3K Buy
33
+17
+106% +$1.33K ﹤0.01% 832
2021
Q3
$1K Hold
16
﹤0.01% 925
2021
Q2
$1K Sell
16
-58
-78% -$4.74K ﹤0.01% 918
2021
Q1
$6K Hold
74
﹤0.01% 709
2020
Q4
$6K Hold
74
﹤0.01% 621
2020
Q3
$6K Hold
74
﹤0.01% 583
2020
Q2
$5K Sell
74
-3
-4% -$213 ﹤0.01% 577
2020
Q1
$5K Buy
77
+3
+4% +$212 ﹤0.01% 565
2019
Q4
$5K Hold
74
﹤0.01% 582
2019
Q3
$5K Hold
74
﹤0.01% 569
2019
Q2
$5K Hold
74
﹤0.01% 565
2019
Q1
$5K Hold
74
﹤0.01% 564
2018
Q4
$4K Hold
74
﹤0.01% 553
2018
Q3
$4K Hold
74
﹤0.01% 561
2018
Q2
$5K Hold
74
﹤0.01% 541
2018
Q1
$5K Buy
+74
New +$5.33K ﹤0.01% 532

Other funds holding CL

Bedel Financial Consulting's CL Position: Q2 2022 in Review

Bedel Financial Consulting sold out of Colgate-Palmolive (CL) in Q2 2022, closing a stake of 16 shares — an estimated $1K sold.

Bedel Financial Consulting first reported a position in CL in Q1 2018 and held it in 17 quarters. The position peaked at $6K in Q1 2021. 1,668 funds tracked by Wall St. Rank hold CL as of Q2 2022.

  • Bedel Financial Consulting reported no remaining Colgate-Palmolive position as of Q2 2022 after selling out during the quarter.
  • Bedel Financial Consulting sold 16 Colgate-Palmolive shares in Q2 2022, an estimated $1K.
  • Bedel Financial Consulting first reported a position in Colgate-Palmolive in Q1 2018 and held it in 17 quarters.
  • Bedel Financial Consulting's Colgate-Palmolive position peaked at $6K in Q1 2021.
  • 1,668 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2022.

Based on Bedel Financial Consulting's 13F filing for Q2 2022, filed 4 Aug 2022.